Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose

Published:2020-01-21 Issue:2 Volume:86 Page:258-273
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Westerdijk Kim¹^ORCID,Desar Ingrid M.E.¹,Steeghs Neeltje²,Graaf Winette T.A.¹²,Erp Nielka P.³^ORCID,

Affiliation:

1. Department of Medical OncologyRadboud University Medical Center Nijmegen the Netherlands

2. Department of Medical OncologyNetherlands Cancer Institute, Antoni van Leeuwenhoek hospital Amsterdam the Netherlands

3. Department of Clinical PharmacyRadboud University Medical Center Nijmegen the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14185

Reference152 articles.

1. Tyrosine Kinases as Targets for Cancer Therapy

2. Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors

3. Clinical pharmacokinetics of tyrosine kinase inhibitors

4. Clinically relevant drug interactions with multikinase inhibitors: a review

5. Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

2. Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer;British Journal of Clinical Pharmacology;2024-08-06

3. Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort;Clinical Pharmacokinetics;2024-07

4. Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes;ESMO Open;2024-06

5. Therapeutic drug monitoring in anticancer agents: perspectives of Australian medical oncologists;Internal Medicine Journal;2024-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3